brochure
INBRX-106 Hexavalent Anti-OX40 Agonist Inhibrx Solid Tumors
investor_presentation
Let us design a presentation that delivers.
1 Pages
Inhibrx 2022 Investor Presentation - Clinical Pipeline Update
46 Pages
presentation
Inhibrx INBRX-109 Phase 1 Ewing Sarcoma Clinical Trial 2021
conference
We turn ideas into stunning slides.
Inhibrx INBX Investor Presentation September 2023
36 Pages